which glp-1 has fewest side effects Comparative safety and of semaglutide and tirzepatide: Implications for clinical decision-making in obesity management Comparing Ozempic, Wegovy and Other
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 34.Li W., Zhou Q., Cong Z., Yuan Q., Li W., Zhao F., Xu H.E., Zhao L.H., Yang D., Wang M.W
Ongoing trials are evaluating their potential benefits in populations with type 2 diabetes mellitus and either CKD or MASLD [101,102]
A 180-degree turnaround in thinking There is a pernicious perception that GLP-1s are a way for the lazy and/or rich to cheat at weight loss
Aubrey B
In a similar analysis of the Swedish National Diabetes Register, a decreasing trend in standardised incidence rates of diabetic nephropathy in people with type 1 diabetes was observed from 2001 to 2019, with no changes in the rates of ESKD over the same period [5]
These stronger results make Tirzepatide an appealing choice for patients who have struggled with stubborn weight challenges
